Benneyworth, Michael A.

Synapse-specific astrocyte gating of amygdala-related behavior

Martin-Fernandez, M., Jamison, S., Robin, L. M., Zhao, Z., Martin, E. D., Aguilar, J., Benneyworth, M. A., Marsicano, G., & Araque, A. (2017) · Nature Neuroscience

Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms

Cited by 345

Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction

Balu, D. T., Li, Y., Puhl, M. D., Benneyworth, M. A., Basu, A. C., Takagi, S., Bolshakov, V. Y., & Coyle, J. T. (2013) · Proceedings of the National Academy of Sciences

Schizophrenia research and treatmentAmino Acid Enzymes and Metabolism

Cited by 217

Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications

Coyle, J. T., Basu, A., Benneyworth, M., Balu, D., & Konopaske, G. (2012) · Handbook of Experimental Pharmacology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 180

Antisense oligonucleotide–mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles

Friedrich, J., Kordasiewicz, H. B., O’Callaghan, B., Handler, H. P., Wagener, C., Duvick, L., Swayze, E. E., Rainwater, O., Hofstra, B., Benneyworth, M., et al. (2018) · JCI Insight

Genetic Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis Research

Cited by 121

Mechanisms underlying the activation of G-protein–gated inwardly rectifying K + (GIRK) channels by the novel anxiolytic drug, ML297

Wydeven, N., Marron Fernandez de Velasco, E., Du, Y., Benneyworth, M. A., Hearing, M. C., Fischer, R. A., Thomas, M. J., Weaver, C. D., & Wickman, K. (2014) · Proceedings of the National Academy of Sciences

Ion channel regulation and functionNeuroscience and Neuropharmacology Research

Cited by 109